Learn About Peripheral Arterial Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Peripheral Arterial Disease on CME Webcast. On this on-line program, we are going to update you about new developments in peripheral artery disease. I’m pleased to introduce our guests. Dr. Michael Go is an Associate Professor of Surgery from the Division of Vascular Surgery here at Ohio State. And Dr. Said Atway is an Assistant Professor of Orthopedics from the Division of Podiatry.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review the anatomy and pathophysiology of PAD; and Review the demographics and diagnosis of PAD.

You’ll also learn about the following:

  • Limb preservation programs
  • Presenting signs and symptoms of foot ischemia
  • Tests used in evaluation of suspected peripheral arterial disease
  • Hyperbaric oxygen

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Pulmonary Hypertension

OSUWexnerbloglogo2014 CME Webcast Discusses Pulmonary Hypertension. Today on MedNet, we’re going to review the causes and diagnosis of pulmonary hypertension as well as the currently available treatments. On this CME webcast, in the studio, are pulmonary hypertension specialists from the Ohio State University. Dr. Shaun Smith is a pulmonologist and Assistant Professor of Internal Medicine. And Dr. Veronica Franco is a cardiologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: PROVIDE basic determination if a patient may respond to calcium channel blockers for treatment of pulmonary hypertension; DETERMINE when a patient should be started on parental prostacyclins; DISCUSS the hemodynamic definition, classification and epidemiology of pulmonary arterial hypertension; and REVIEW the signs and symptoms of pulmonary arterial hypertension as well as the diagnostic algorithm.

You’ll also learn about the following:

  • The causes of pulmonary hypertension
  • Which patients should be treated with vasodilators
  • Vasodilator testing during the right heart cath
  • Selecting the right drug
  • Which patients do not benefit by vasodilators?
  • Anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.